Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

El En (ELEN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.23 +0.59    +5.07%
11:35:06 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Italy
ISIN:  IT0005453250 
  • Volume: 175,380
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 11.61 - 12.25
El En 12.23 +0.59 +5.07%

El En Company Profile

 
Get an in-depth profile of El En, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

EL.En. S.p.A. engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; EchoLaser, an integrated laser-ultrasound system that allows diagnosis and treatment of benign and malignant lesions; hair removal and non-invasive body contouring products; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also develops laser systems that helps professional of restoration bring back masterpieces to their original condition; and provides after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.

Contact Information

Address Via Baldanzese, 17
Calenzano, 50041
Italy
Phone 39 05 58 82 68 07
Fax 39 05 58 83 28 84

Top Executives

Name Age Since Title
Barbara Bazzocchi 83 1989 MD & Executive Director
Alberto Pecci 80 2002 Non-Executive Director
Paolo Caselli 57 2003 Statutory Auditor
Michele Legnaioli 59 2000 Non-Executive Independent Board Member
Rita Pelagotti 67 - Statutory Auditor
Gabriele Clementi 72 1989 Chairman, President & MD
Andrea Cangioli 58 1992 MD & Executive Director
Leonardo Masotti 84 - President of the Scientific Committee
Fabia Romagnoli 60 2015 Non-Executive Independent Board Member
Daniela Toccafondi - - Independent Director
Carlo Carrera - 2022 Chairman of the Board of Statutory Auditors
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ELEN Comments

Write your thoughts about El En
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Francesco Leo
Francesco Leo Dec 02, 2019 3:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cosa consigliate?
Andrea Tribulini
Andrea Tribulini Oct 05, 2018 10:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nuovo dietro front per El.En. che cancella il tentativo di reazione messo a segno a inizio mese da 20,22 circa mettendo sotto pressione un supporto critico definito in quest'area dai minimi allineati di febbraio e novembre 2017.Sotto questo livello verrebbe compromesso il quadro grafico rialzista in atto da oltre sei anni con un elevato rischio di completamento di un doppio massimo disegnato da area 34,50, con target finale a 6 euro circa, minimi di fine 2014, e supporti intermedi a 18,60 e 15,60. Reazioni dai valori attuali dovranno invece ricondurre le quotazioni sopra 24,16, minimo di marzo, per essere convincenti.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email